Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Soleno Therapeutics Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 142 | 1 | 166 | +25 |
| Shares | 47.1M | 150.0K | 51.0M | +4.07M (+8.7%) |
| Value | $2.38B | $7.57M | $2.29B | −$77.4M (−3.3%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (49)
Institutions that held Soleno Therapeutics Inc at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (24)
Institutions that held Soleno Therapeutics Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ikarian Capital, LLC | 221,437 | $11.2M |
| StemPoint Capital LP | 123,177 | $6.22M |
| Schonfeld Strategic Advisors LLC | 54,273 | $2.74M |
| Twinbeech Capital LP | 53,243 | $2.69M |
| Boothbay Fund Management, LLC | 51,710 | $2.61M |
| Tudor Investment Corp Et Al | 41,888 | $2.11M |
| Alps Advisors Inc | 29,168 | $1.47M |
| Hudson Bay Capital Management LP | 17,220 | $869.4K |
| NEOS Investment Management LLC | 14,033 | $708.5K |
| Victory Capital Management Inc | 13,509 | $682.1K |
| Corbin Capital Partners, L.P. | 11,685 | $590.0K |
| Engineers Gate Manager LP | 11,157 | $563.3K |
| Valence8 US LP | 9,706 | $490.1K |
| Virtu Financial LLC | 9,706 | $490.0K |
| Deerfield Management Company, L.P. (Series C) | 6,774 | $342.0K |
| Dimensional Fund Advisors LP | 4,522 | $228.3K |
| Nebula Research & Development LLC | 4,358 | $220.0K |
| RMB Capital Management, LLC | 4,000 | $202.0K |
| Acadian Asset Management LLC | 1,523 | $76.0K |
| Capital Performance Advisors LLP | 17 | $858 |
| Russell Investments Group, Ltd. | 11 | $555 |
| Smartleaf Asset Management LLC | 9 | $442 |
| National Bank of Canada | 1 | $50 |
| Capital Advisors, Ltd. LLC | 6 | $0 |
Not filed for Q4 2024 yet (1)
Institutions that held Soleno Therapeutics Inc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ghost Tree Capital, LLC | 150,000 | $7.57M |